- U.S. health officials will be adding new safety warnings of memory loss, confusion, high blood sugar, and type II diabetes as possible side effects to popular cholesterol-lowering drugs called statins, the U.S. Food and Drug Administration announced on Tuesday.
- While grapefruit juice may be part of a healthy diet, U.S. health officials warned on Wednesday that grapefruit juice and fresh grapefruit can dangerously interfere with the way some prescription...
- After health officials publically revealed this week that they have alerted 19 oncology practices purchasing "unapproved cancer medicines," that could have also purchased the bogus cancer drug Avastin that did not contain the widely-used drug's active ingredient, the news sparked new fears over more counterfeit treatments that could also be on the U.S. market.
- A gut hormone that suppresses appetite can be clinically beneficial to weight loss as well reduced blood pressure and cholesterol levels in overweight or obese patients, researchers said Wednesday.
- Scientists have found a possible target for drugs that could help lower Low-density lipoprotein (LDL), the 'bad cholesterol' in humans.
- The U.S. Food and Drug Administration on Friday approved the Merck Co. drug Juvisync, the first pill designed to treat diabetes and high cholesterol at the same time.
- Scientists from the University of Warwick have discovered why a newly found form of cholesterol seems to be 'ultra-bad', leading to increased risk of heart disease. The discovery could lead to new treatments to prevent heart disease particularly in people with type 2 diabetes and the elderly.
- The so-called "bad cholesterol" - low-density lipoprotein commonly called LDL - may not be so bad after all, shows a Texas A&M University study that casts new light on the cholesterol debate, particularly among adults who exercise.
- This week at Experimental Biology (EB) 2011 in Washington, D.C., long-standing beliefs about dietary cholesterol intake and cardiovascular disease risk were examined as part of a scientific symposium and a variety of poster presentations. Experts from leading institutions discussed existing and emerging science regarding dietary cholesterol intake and its association with heart disease risk, dispelling some commonly heard myths.
- Researchers at Karolinska Institutet have shown in a new study on mice, that cell therapy can be used to reverse the effect of 'bad' LDL cholesterol and reduce the inflammation that leads to atherosclerosis. The new cell therapy, which is presented in the prestigious scientific journal Circulation, can open the way for new therapies for stroke and myocardial infarction if the results prove translatable to humans.
- A University of Missouri researcher believes there could be a new drug compound that could kill breast cancer cells. The compound might also help with controlling cholesterol.
- Recent studies conducted at the Institut de recherches cliniques de Montréal (IRCM) on a group of PCSK enzymes could have a positive impact on health, from cholesterol to osteoporosis. A team led by Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology research unit, has published six articles in prestigious scientific journals over the past four months, all shedding light on novel functions of certain PCSK enzymes.
Hypercholesterolemia is the presence of high levels of cholesterol in the blood. A number of lifestyle changes are recommended in those with high cholesterol including: smoking cessation, limiting alcohol consumption, physical activity, maintaining a healthy weight, and a diet low in saturated fats.